Xenon Pharmaceuticals Inc (XENE)
38.09
-0.95
(-2.43%)
USD |
NASDAQ |
May 31, 16:00
38.06
-0.03
(-0.08%)
After-Hours: 20:00
Xenon Pharmaceuticals Research and Development Expense (TTM): 172.25M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 172.25M |
| December 31, 2023 | 167.51M |
| September 30, 2023 | 161.27M |
| June 30, 2023 | 147.82M |
| March 31, 2023 | 125.92M |
| December 31, 2022 | 105.77M |
| September 30, 2022 | 92.82M |
| June 30, 2022 | 82.28M |
| March 31, 2022 | 78.52M |
| December 31, 2021 | 75.46M |
| September 30, 2021 | 68.54M |
| June 30, 2021 | 62.70M |
| March 31, 2021 | 55.04M |
| December 31, 2020 | 50.52M |
| September 30, 2020 | 47.31M |
| June 30, 2020 | 44.01M |
| March 31, 2020 | 41.50M |
| December 31, 2019 | 38.84M |
| September 30, 2019 | 33.50M |
| June 30, 2019 | 29.99M |
| Date | Value |
|---|---|
| March 31, 2019 | 27.20M |
| December 31, 2018 | 23.63M |
| September 30, 2018 | 23.63M |
| June 30, 2018 | 24.54M |
| March 31, 2018 | 25.24M |
| December 31, 2017 | 25.57M |
| September 30, 2017 | 23.57M |
| June 30, 2017 | 22.37M |
| March 31, 2017 | 21.37M |
| December 31, 2016 | 19.83M |
| September 30, 2016 | 19.70M |
| June 30, 2016 | 17.52M |
| March 31, 2016 | 16.09M |
| December 31, 2015 | 15.15M |
| September 30, 2015 | 14.34M |
| June 30, 2015 | 13.76M |
| March 31, 2015 | 12.66M |
| December 31, 2014 | 11.77M |
| September 30, 2014 | 11.06M |
| June 30, 2014 | 10.42M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
29.99M
Minimum
Jun 2019
172.25M
Maximum
Mar 2024
84.08M
Average
72.00M
Median
Research and Development Expense (TTM) Benchmarks
| Acasti Pharma Inc | 4.638M |
| Aurinia Pharmaceuticals Inc | 49.64M |
| Edesa Biotech Inc | 3.860M |
| Lexaria Bioscience Corp | 2.961M |
| ESSA Pharma Inc | 23.05M |